Influenza

Researchers say findings demonstrate the capacity to use an existing influenza vaccine effectiveness network to study a large immunocompromised population.

COVID-19, influenza, and RSV will be the topics of a different types of sessions examining the history, new diagnostics, prevention, and future treatments during IDWeek 2023.

Dr John Russell and Neil Skolnik comment on how to translate the advisory committee on immunization practices influenza vaccination recommendations to patients.

Dr Neil Skolnik reviews the role of real-world data to examine the efficacy of influenza vaccines and their impact on influenza related complications.

IDWeek 2023: Imagine an intriguing hot topic in infectious disease and you'll find a session or 2 where you can learn more and then choose the next topic, rinse, and repeat.

A panel of experts in vaccination share their thoughts on the optimal timing and administration of an influenza vaccine for the general public.

Dr Wendy Wright reviews the differences between influenza strains and the rationale for the inclusion of multiple viral strains within flu vaccines.

Influenza B is the diagnosis and the patient wants to start antiviral therapy. Factoring in CDC guidance, patient preference, and price, which of the 4 options makes most sense?

Less than one-quarter of US adults surveyed said they would "definitely" get the shot while 33% stated they would "definitely not" get the new vaccine.

Neil Skolnik, MD, reviews the currently available vaccine technologies, highlighting their mechanisms of action and individual delivery methods.

A panel of experts in vaccination uptake strategies discuss their best practices for empowering their patients to obtain flu vaccines and discuss how to personalize these conversations.

Jacinda Abdul-Mutakabbir, PHARMD, MPH, AAHIVP, leads a conversation on the importance of vaccination in the defense and protection against viral infections, such as the flu.

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, shares her thoughts on the changing perception of influenza and influenza vaccination post the COVID-19 pandemic.

"Keep the vaccination conversation going this year, even though your patients, and probably you, too, have grown tired of the issues and your team is worn out."

Patients hospitalized with COVID-19 were 2-times more likely to develop persistent hypertension than their influenza counterparts, according to results.

The triple assay can identify and differentiate influenza, COVID-19, and respiratory syncytial virus in approximately 2 hours and is already in use.

In the post COVID-19 pandemic health care emergency era, private and public insurance entities will continue full coverage of the shots - but what about the uninsured?

Reducing American's risk for CHD and cardiovascular events gets harder as the population ages and obesity rates climb. Can a vaccine help?

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

In most patients with viral respiratory infections, the chance of bacterial coinfection is low and antibiotics can be withheld safely, say authors of a new study.

Your daily dose of clinical news you may have missed.

ACC 2023. Electronic nudges highlighting the potential cardiovascular benefits of flu vaccination led to a modest uptake in vaccination rates among older adults in Denmark, according to results of the NUDGE-FLU trial.

The first-of-its kind combination home-based test matched lab-based PCR tests for identification of influenza A and B and COVID-19.

Your daily dose of clinical news you may have missed.

The large biobank-based study found 22 pairings of a neurodegenerative disorder and a previous viral infection. Vaccines exist against several of those viruses.